Suzanne Bijl

Suzanne Bijl has a diverse work experience spanning several companies and roles. Suzanne started their career as a PhD Graduate at Utrecht University, where they focused on studying functional changes in the brains of social drinkers. Suzanne then worked as a CRA (Clinical Research Associate) at CRA BV and Roche Nederland BV before joining Janssen-Cilag as a Clinical Trial Manager. Suzanne later worked at Genzyme Europe BV as a CR CRA Coordinator/Trainer and Inhouse CRA. Suzanne then joined PPD, where they held various roles including Principal Clinical Team Manager and Associate Director Project Delivery. Suzanne also owned HippoSupport, a company specializing in horse health services. Currently, they are serving as the Head Clinical Operations EMEA at Amylyx Pharmaceuticals.

Suzanne Bijl obtained their PhD in Biological Psychology from Utrecht University, completing their studies from 1995 to 2004. Prior to that, there is no available information about their education, as indicated by the "null" values for start and end years, as well as the absence of degree name and field of study, for St. Bonifatius school.